A prostate biopsy is a procedure in which a doctor uses a thin, spring-loaded needle to remove small samples of tissue from the prostate gland so they can be examined under a microscope for signs of cancer.1PubMed Central. Antibiotic prophylaxis for transperineal prostate biopsy The whole process, from positioning to the last tissue sample, usually takes between 15 and 30 minutes, though preparation and recovery add time on either side. Because the procedure sounds intimidating but is far more routine than most people expect, understanding what actually happens at each stage tends to take much of the anxiety out of it.
Why the Biopsy Gets Ordered
A prostate biopsy is not the first step in screening. It comes after something else raises a flag. That something is usually an elevated PSA blood test, an abnormal digital rectal exam, or both. More recently, an MRI scan of the prostate showing a suspicious area has become a common trigger. The biopsy is the only way to confirm whether cancer is present. PSA levels and imaging can suggest a problem, but tissue under a microscope is what delivers the actual diagnosis.
Not every elevated PSA leads to a biopsy. PSA can rise from infections, an enlarged prostate, recent exercise, or even ejaculation. Your urologist weighs several factors, including your age, PSA trend over time, family history, and MRI findings if available, before recommending a biopsy. If the decision is made to go ahead, you will receive specific instructions for the days leading up to it.
Preparing in the Days and Hours Before
Preparation typically starts about a week out. If you take blood thinners such as warfarin, aspirin, or newer anticoagulants, your doctor will likely ask you to stop them several days before the procedure, after checking with the prescribing physician. Blood thinners increase the risk of bleeding from the biopsy sites, so pausing them is standard.
The night before or the morning of the procedure, you may be asked to use a Fleet enema to clear the lower rectum, especially if the biopsy will be done through the rectal wall. A clean rectum improves the ultrasound image quality and reduces the amount of bacteria near the needle path. You will also be prescribed a short course of antibiotics to take before the biopsy.1PubMed Central. Antibiotic prophylaxis for transperineal prostate biopsy The specific antibiotic and timing depend on the approach being used and your institution’s protocol, but the goal is to have the drug circulating in your bloodstream before the needle punctures any tissue.
You should also arrange for someone to drive you home, particularly if sedation is part of the plan. Eating a light meal beforehand is usually fine for procedures done under local anesthesia, though your clinic will give you specific fasting instructions if sedation or general anesthesia is involved.
Two Routes to the Prostate
The needle has to reach the prostate, and there are two main paths a doctor can take. Understanding the difference matters because it affects your experience, the preparation involved, and the risk of certain complications.
The Transrectal Approach
In a transrectal biopsy, you lie on your side with your knees pulled toward your chest. The doctor inserts a thin ultrasound probe into the rectum, which produces a live image of the prostate on a screen. Using that image as a guide, a spring-loaded biopsy needle is passed through the rectal wall and into the prostate. Each time the needle fires, it captures a thin core of tissue about the width of a pencil lead and roughly 15 to 20 millimeters long. The doctor typically takes 10 to 12 cores from different areas of the gland in a systematic pattern to sample it thoroughly.
Each needle fire produces a quick, sharp sensation, often described as a snap or a sting. The whole sampling phase lasts only a few minutes. The transrectal route has been the standard for decades and remains widely used, though it carries a somewhat higher risk of infection because the needle passes through bowel tissue on its way to the prostate.
The Transperineal Approach
In a transperineal biopsy, the needle enters through the perineum, the patch of skin between the scrotum and the anus. You lie on your back with your legs supported in stirrups. The ultrasound probe is still placed in the rectum to visualize the prostate, but the needle itself never passes through the rectal wall. Instead, it goes through cleaned, prepped skin directly into the gland.
This approach has gained popularity because it significantly lowers the chance of bacterial infections. Because the needle avoids the rectum’s bacterial environment, urinary tract infections, bloodstream infections, and sepsis occur far less often compared with the transrectal route.2Taylor & Francis Online. Infection rates of trans-perineal versus trans-rectal prostate biopsy: A Middle Eastern tertiary center experience-Time for a change? The trade-off is that the perineal skin needs a local anesthetic injection (or sometimes general anesthesia), so the prep and numbing phase is a bit more involved. Temporary difficulty urinating can also be slightly more common with this route.
MRI-Targeted Biopsy and How It Differs from Systematic Sampling
Traditionally, prostate biopsies were performed “systematically,” meaning the doctor sampled evenly spaced locations across the gland regardless of what the imaging showed. That approach works, but it can miss cancers in areas that were not sampled and can also detect tiny, slow-growing cancers that might never cause harm.
MRI-targeted biopsy changes the strategy. Before the biopsy, a multi-parametric MRI scan identifies suspicious areas. During the biopsy, those specific spots get extra needle cores aimed directly at them, usually in addition to the systematic pattern. The PROMIS study, a large validation trial, found that MRI-guided targeting could detect roughly 18% more cases of clinically significant cancer compared with the standard approach of ultrasound-guided transrectal biopsy alone.3The Lancet. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
In practice, many centers now combine both strategies in a single session. You get the systematic cores for broad coverage and targeted cores at any MRI-suspicious lesions. The fusion of MRI images with the real-time ultrasound is handled by software that overlays the two image sets, giving the doctor a roadmap for where to aim. The total number of cores taken may be higher than a purely systematic biopsy, but the improved accuracy often makes the additional samples worthwhile.
How Pain Is Managed During the Procedure
One of the most common concerns before a prostate biopsy is whether it will hurt. The honest answer is that it is uncomfortable but manageable for most people, and modern pain control techniques make a meaningful difference.
For transrectal biopsies, the standard method is a periprostatic nerve block: the doctor injects a local anesthetic around the bundle of nerves at the base of the prostate using the same ultrasound probe already in place. A systematic review and network meta-analysis found that this nerve block, whether used alone or combined with a numbing gel applied inside the rectum, significantly reduces biopsy pain compared with a placebo or rectal gel alone.4Central European Journal of Urology. Effectiveness of periprostatic block to prevent pain in transrectal prostate biopsy: a systematic review and a network meta-analysis Most patients describe the individual needle fires as brief pinches or pressure sensations once the block is working.
For transperineal biopsies, the perineal skin gets injected with a local anesthetic, and many centers also perform a periprostatic block. Some institutions offer light sedation or even short general anesthesia for the transperineal approach, particularly if a large number of cores are planned or the patient is especially anxious. If sedation is offered, ask your doctor what type and how long recovery takes, because that affects whether you need a driver and how the rest of your day goes.
What Happens Right After the Biopsy
Once the last sample is taken and the needle and probe are removed, you will rest briefly in the clinic or procedure room. Staff will check your vital signs and make sure you can urinate before you leave. The tissue samples are placed into labeled containers with preservative and sent to a pathology lab, where a specialist will examine them under a microscope. Results usually take between five and ten business days, though timelines vary by lab.
You can expect some bleeding afterward, and it helps to know what is normal so you do not panic. Blood in the urine is extremely common and can last a few days. Blood in the stool may appear if the biopsy was transrectal and usually clears within a day or two. Blood in the semen is the symptom that surprises people the most. Called hemospermia, it is actually the most frequent bleeding-related side effect of transrectal biopsy and can persist for several weeks, sometimes even a couple of months.5PubMed Central. Hemosepermia after transrectal ultrasound-guided prostatic biopsy: A prospective study It looks alarming but is almost always harmless and resolves on its own.
Most men return to normal activities within a day or two. Avoid heavy lifting and vigorous exercise for about 48 hours. Drink plenty of water to flush the urinary tract and help clear any blood from the urine faster. Sexual activity can usually resume after a few days, though you should follow whatever specific guidance your urologist provides.
Complications and Warning Signs Worth Knowing
Serious complications from prostate biopsy are uncommon, but they do occur, and knowing which symptoms are red flags can save you a trip to the emergency room or, more importantly, prompt you to go when you should.
Infection is the complication doctors worry about most. Despite prophylactic antibiotics, infectious complications have been rising over time, largely because of increasing antibiotic resistance, and infection remains the most common reason men are hospitalized after a prostate biopsy.6PubMed Central. Systematic review of complications of prostate biopsy Symptoms to watch for include fever above 38°C (100.4°F), chills, pain that worsens rather than improves over the first 24 to 48 hours, and cloudy or foul-smelling urine. If any of these appear, contact your urologist or go to an emergency department right away. Sepsis can escalate quickly, and early treatment with intravenous antibiotics is critical.
Urinary symptoms are also common. Up to about a quarter of men experience temporary lower urinary tract symptoms after biopsy, including a weak stream, increased urgency, or frequent urination. Frank urinary retention, where you cannot urinate at all, occurs in fewer than 2% of cases, though rates are slightly higher after transperineal template biopsies.6PubMed Central. Systematic review of complications of prostate biopsy If you cannot pass urine within six to eight hours after the procedure, seek medical attention promptly, as a catheter may need to be placed temporarily.
Significant rectal bleeding is rare but possible with the transrectal approach. A small amount of blood on toilet paper is expected. Passing clots or bleeding that does not stop after 30 minutes of sustained pressure warrants a call to your doctor. Erectile dysfunction after a prostate biopsy is occasionally reported, but large-scale data suggest it is usually temporary and related to anxiety or post-procedure discomfort rather than physical nerve damage from the needle.
What Happens If the Results Come Back Positive
If cancer cells are found, the pathology report will include a Gleason score, now often reported as part of a Grade Group system from 1 to 5. Grade Group 1 represents low-risk cancer that grows slowly and may only need monitoring, while Grade Group 5 indicates the most aggressive pattern. The report will also note how many of your biopsy cores contained cancer and what percentage of each core was involved, giving your urologist a picture of how widespread the disease is within the gland.
Treatment decisions are not made from the biopsy alone. Your doctor will combine the pathology results with your PSA levels, imaging findings, age, and overall health to recommend a management plan. For very low-risk cancers, active surveillance with regular PSA checks and repeat biopsies is increasingly common and avoids the side effects of immediate treatment. For higher-risk cancers, options include surgery, radiation therapy, or other approaches. The biopsy is the beginning of the decision-making conversation, not the end of it.
When a Repeat Biopsy Is Needed
A negative biopsy does not always mean the case is closed. Because the standard biopsy samples only a fraction of the prostate’s total volume, cancers can be missed, particularly if they sit in areas the needle did not reach. If your PSA continues to rise after a negative biopsy or if subsequent MRI scans show a new or growing suspicious area, your urologist may recommend a second biopsy.
Repeat biopsies are performed using the same techniques described above, though the strategy may shift. If the first biopsy was purely systematic, the second one will likely incorporate MRI-targeted cores. If the first was transrectal, the doctor may recommend a transperineal approach for broader sampling of areas that are harder to reach from the rectal side, such as the anterior (front) portion of the gland. The preparation, recovery, and potential complications are essentially the same as the first time around. While no one looks forward to a second biopsy, the procedure itself is no more difficult than the first, and the refined targeting tends to improve diagnostic confidence.
Emerging Alternatives and the Shifting Landscape
The prostate biopsy as a procedure is not standing still. Robotic transperineal platforms are being tested at some centers, where software-guided arms position the needle with millimeter-level precision based on fused MRI and ultrasound images. These systems aim to improve the consistency of targeting while potentially reducing the number of cores needed to get an accurate diagnosis.
Liquid biopsy research, which looks for tumor-derived DNA fragments or other cancer markers in blood or urine, is also advancing, though no liquid biopsy currently replaces a tissue biopsy for a definitive prostate cancer diagnosis. Genomic tests performed on biopsy tissue itself, such as Decipher and Oncotype DX Prostate, are already being used in clinical practice to help predict how aggressive a detected cancer is and whether active surveillance versus immediate treatment makes more sense. These tests analyze gene expression patterns in the sampled tissue, adding a molecular layer of information on top of the Gleason grade. None of these innovations eliminate the needle biopsy yet, but they are steadily refining when biopsies are done, how they are targeted, and what information they produce.